Position in ROIV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,494,160
-$773,939 QoQ
Shares Held
98,733
-35.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#167
of 494 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$14,156
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ROIV ranks #30 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ROIV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,156 | 400 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $3,494,160 | 98,733 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $144,040 | 5,200 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $501,370 | 18,100 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $4,268,099 | 154,083 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,073,933 | 49,490 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $1,877,050 | 86,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $1,176,140 | 54,200 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $199,716 | 13,200 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,337,492 | 88,400 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $134,113 | 11,900 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $98,049 | 8,700 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $52,371 | 4,647 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $2,366 | 200 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $500,409 | 42,300 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $61,516 | 5,200 | Put | Sole | 2025-02-13 | |
| 2024-09-30 | $580,462 | 50,300 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $78,472 | 6,800 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $912,191 | 86,300 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $411,173 | 38,900 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $1,054 | 100 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $1,275 | 121 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $123,318 | 11,700 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $84,225 | 7,500 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $5,300,593 | 472,003 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||